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Longitudinals lacking (lola) is one of the most com-
plex genes in Drosophila melanogaster, encoding
up to 20 protein isoforms that include key transcrip-
tion factors involved in axonal pathfinding and neural
reprogramming. Most previous studies have em-
ployed loss-of-function alleles that disrupt lola com-
mon exons, making it difficult to delineate isoform-
specific functions. To overcome this issue, we have
generated isoform-specific mutants for all isoforms
using CRISPR/Cas9. This enabled us to study spe-
cific isoforms with respect to previously character-
ized roles for Lola and to demonstrate a specific
function for one variant in axon guidance via activa-
tion of the microtubule-associated factor Futsch.
Importantly, we also reveal a role for a second variant
in preventing neurodegeneration via the positive
regulation of a key enzyme of the octopaminergic
pathway. Thus, our comprehensive study expands
the functional repertoire of Lola functions, and it
adds insights into the regulatory control of neuro-
transmitter expression in vivo.
INTRODUCTION
lola is among the most complex loci in Drosophila, giving rise to
at least 80 different mRNA isoforms through alternative cis- and
trans-splicing as well as via multiple promoter activity (Figure 1A)
(Goeke et al., 2003; Horiuchi et al., 2003; Ohsako et al., 2003;
Zhang et al., 2003). In total, lola encodes 20 known protein iso-
forms (Lola A–Lola T) that contain a common N-terminal BTB
domain, with 17 isoforms encoding a unique zinc-finger motif
in their C-terminal variable exons (Figure 1B). Lola has been
shown to act as a transcription factor with regulatory roles in
axon growth and guidance during embryogenesis, and it is
also required for maintaining neurons in a differentiated state
of the developing brain (Giniger et al., 1994; Goeke et al., 2003;
Southall et al., 2014). In addition, Lola has been found to control
stem cell maintenance and germ cell differentiation in the
Drosophila testis, programmed cell death during oogenesis,Cell Repo
This is an open access article under the CC BY-Nand gonad formation in early embryo (Bass et al., 2007; Davies
et al., 2013; Tripathy et al., 2014).
Most experiments investigating Lola function utilized loss-of-
function alleles containing mutations in the N-terminal constitu-
tive region, which affect all 20 Lola isoforms and give pleiotropic
effects in vivo (Giniger et al., 1994; Madden et al., 1999;
Crowner et al., 2002; Goeke et al., 2003; Horiuchi et al., 2003;
Spletter et al., 2007; Zheng and Carthew, 2008; Gates et al.,
2011; Fukui et al., 2012; Davies et al., 2013; Southall et al.,
2014). Studies of specific isoformmutant alleles, which are avail-
able only for Lola-K, -J, -L, and -T, revealed functions in distinct
physiological processes (Goeke et al., 2003; Bass et al., 2007;
Davies et al., 2013; Tripathy et al., 2014; Peng et al., 2016). Iso-
forms Lola-K and Lola-L are both involved in two unrelated
mechanisms, which include motor nerve development and
germline stem cell maintenance in the male testis, indicating
that at least some Lola isoforms control multiple functions during
development (Goeke et al., 2003; Davies et al., 2013).
To functionally characterize Lola isoforms, we generated mu-
tations using CRISPR/Cas9 for all 20 lola isoforms by respec-
tively targeting the isoform-specific C terminus. Among the
20 lola mutant strains, five are homozygous lethal during early
development while three exhibit clear defects in adult flies. We
demonstrate that mutations targeting lola-F result in severe
disruption of axonal tracts at the embryonic ventral midline.
We found that Lola-F regulates the expression of several axonal
guidance genes, including the microtubule-associated factor
Futsch. Furthermore, flies deficient for lola-A and lola-H display
severe locomotion phenotypes. Finally, lola-O mutant flies are
viable but display a strong degeneration phenotype due to a
defective octopaminergic pathway. Lola-O is specifically ex-
pressed in the subset of neurons that produce octopamine
(OA) and regulates its biogenesis by controlling the expression
of Tyramine beta-hydroxylase (Tbh), which encodes a key enzy-
matic component of this pathway. Together, our data provide a
comprehensive functional characterization of Lola isoforms,
revealing novel roles for previously uncharacterized isoforms.
RESULTS
CRISPR/Cas9-Induced lola Isoform-Specific Knockout
To comprehensively characterize Lola isoforms in vivo, we
generated knockout (KO) flies for each isoform using therts 21, 2911–2925, December 5, 2017 ª 2017 The Author(s). 2911
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. CRISPR/Cas9-Induced lola Isoform-Specific Knockout
(A) Schematic structure of the lola locus. lola comprises 32 exons including 50 UTR exons (white boxes), constitutive exons (black), and 30 alternative exons (gray).
80 putative transcripts encode for 20 protein isoforms, each sharing anN-terminal BTB domain but holding isoform-specific exons encoding for a C-terminal zinc-
finger domain in 17 isoforms. Previously characterized mutations are marked by an asterisk.
(B) Scheme of the 20 lola isoforms (Lola-A–Lola-T). Stripes highlight zinc-finger motifs.
(C) CRISPR/Cas9 approach to systematically mutate each Lola isoform.
(D) Gel analyses of established lolamutants. Agarose gel shows amplicons of respective genomic regions in wild-type (WT, left lane) and CRISPR/Cas9-induced
lola KO flies (D, right lane). Mutation in Lola-M resulted in partial duplications that disrupt the frame. Mutants for lola-G, -J, -K, and -L bear a frameshift and are not
displayed. Lethal alleles are heterozygous and show both the mutant and the wild-type allele.
See also Figures S1 and S2.CRISPR/Cas9 system. In brief, two distinct guide RNAs (gRNAs)
were designed to target the isoform-specific C-terminal exon of
each lola isoform (Figure 1C). In most cases, Cas9 activity re-
sulted in the production of two double-strand breaks, leading
to deletion of the sequence between the two Cas9 target sites
and resulting in a loss-of-function mutation for the respective
lola isoform (Figures 1D and S1).
Our targeted screen resulted in KO flies for all 20 known Lola
isoforms, and mutations in 8 of these isoforms led to a clear
phenotype (Table S1). Five isoform-specific mutations, including
in the already described lola-K, -L, and -T as well as in lola-F and
-N, resulted in lethality during embryonic and early larval stages.
Mutations in lola-A and -H produced viable flies with impaired
locomotion (Figure S2A). Interestingly, lola-H mutants displayed
reduced locomotion, while lola-A mutant flies were hyperactive.
Finally, lola-O mutants survived until adulthood, but they rapidly2912 Cell Reports 21, 2911–2925, December 5, 2017degenerated and died around 2 weeks after hatching. With
the exception of Lola-H and -A, we found that only isoforms
conserved between D. melanogaster and Anopheles gambiae
play important roles during development and in adults (Table
S1), raising the question of the relevance of the non-conserved
Lola isoforms.
Among them, Lola-B was previously shown to play a critical
role in neural stem cell (NSC) differentiation using RNAi (Neu-
m€uller et al., 2011). Upon depletion of Lola-B, NSC proliferation
was shown to be drastically reduced. However, our lola-B KO
flies did not recapitulate this phenotype, suggesting that this ef-
fect was due to off-target activity (Figure S2B). In contrast, mu-
tations in the conserved lola-L and -K reproduced the reported
defects in the innervation of ISNb motoneurons (Figure S2C),
as well as the loss of lola-T in germ cell migration (Figure S2D).
It has been reported that neurons deficient for all Lola isoforms
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Figure 2. lola-F KO Embryos Display Disrupted Axonal Tracts
(A) (Top) Schematic of lola-F genomic region. lola-FStop bears a 2-bp deletion resulting in a premature stop codon downstream of the zinc-finger domain. lola-FZNF
lacks the entire zinc-finger motif. (Bottom) Immunoblotting using the anti-Lola zf5 and anti-Lola antibody on control and lola-F KO lysates of stage 15 embryos is
shown. Arrowheads depict a band specific for Lola-F.
(B) Anti-Lola zf5 immunostaining (green) on stage 13 embryos. Lola-F protein is undetectable in lola-Fstop embryos.
(C) In situ hybridization shows lola-F mRNA (magenta) enrichment in the nervous system, which is absent in lola-FZNF embryos. lola-F mRNA co-localizes with
both the neuronal marker Elav (blue) and NSC marker Dpn (green, lateral view, stage 10/11).
(D) Immunostaining of the VNC using an anti-Fasciclin II antibody (green). lola-F mutants display strong midline crossing of axons (arrowheads), while lolaE76
embryos show more severe axon growth defects (arrows). Neuronal lola-F expression in wild-type disrupts axonal tracts, but it is sufficient to rescue the
phenotype in a lola-F mutant background (stage 15/16 embryos, ventral view). Ectopic lola-H expression is unable to rescue the axonal defects in lola-FStop
mutants.
See also Figures S2 and S3.dedifferentiate into NSCs in the developing nervous system
(Southall et al., 2014) and that Lola-N is able to rescue this
phenotype.We found that depletion of lola-N in the larval or adult
brain bymosaic analysis with a repressible cell marker (MARCM)
did not alter the differentiation state of postmitotic neurons
(Figure S2E; data not shown), hinting to possible functional
redundancy between isoforms. This potential functional redun-
dancy between isoforms might also prevent us from uncovering
additional roles for Lola. Consistent with this, reducing the level
of both Lola-L and Lola-F was recently shown to alter NSC num-
ber, while reduction of either one alone had no effect (Wissel
et al., 2016).Lola-F Is the Main Isoform Required for Axon Guidance
in the Developing Embryo
We generated two different lola-F alleles that were both lethal
during late embryogenesis (Figures 1D, 2A, and S1). One allele
specifically lacks the zinc-finger motif (lola-Fznf), whereas the
second one carries a 2-bp deletion downstream of the zinc-
finger domain (lola-Fstop), leading to a frameshift and premature
stop codon. We confirmed the depletion of Lola-F protein in both
homozygous mutant embryos, while the overall levels of other
isoforms were virtually unchanged or only slightly reduced (Fig-
ure 2A). Immunostaining using a Lola-F-specific antibody further
confirmed the absence of Lola-F protein in lola-FStop mutantCell Reports 21, 2911–2925, December 5, 2017 2913
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Figure 3. Lola-F Regulates Neuronal Projection by Activation of Axon Guidance Genes
(A) Transcriptome analysis of lola-FStop and lolaE76 embryos reveals 217 commonly downregulated genes. Highlighted are examples of shared target genes
involved in neuronal development.
(B) qRT-PCR for selected genes on lolaE76 and lola-FStop mutant RNA extracted from stage 15 embryos. ANOVA t test was performed (**p < 0.01 and *p < 0.05).
Data are represented as median ± SD from three technical replicates.
(C) Track example of poly-A-selected RNA-seq at the futsch locus.
(D) In situ hybridization reveals reduced futsch mRNA (magenta) in lola-FStop embryos (stage 15, lateral view).
(E) Anti-22C10 immunostaining (green) detects reduced Futsch levels in lola-FStop mutants (stage 15 embryo, lateral view).
(legend continued on next page)
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embryos (Figure 2B). Moreover, expression of a lola genomic
construct rescued the lethal effect of both mutants, confirming
the specificity of our alleles (data not shown). Expression anal-
ysis by in situ hybridization revealed a strong enrichment
of lola-F mRNA in the developing CNS, which was lost in
lola-FZNF embryos (Figure 2C). More precisely, lola-F localized
in both NSCs and differentiated neurons, suggesting possible
functions during neurogenesis. At late embryogenesis and in
larvae, lola-F RNA expression became mainly restricted to
NSCs (Figures 2C and S3A).
To address the role of Lola-F, we stained control and lola-FKO
embryoswith anti-Fasciclin II to label axon tracts of stage 15 em-
bryos (Figure 2D). The loss of all Lola isoforms was previously
shown to impair axonal growth and pathfinding at the ventral
midline, a phenotype we could recapitulate using the lolaE76-
null mutant allele. Remarkably, depletion of Lola-F also resulted
in severe disruptions of the ventral nerve cord (VNC). Compared
to the null mutant, axons extended slightly further but several
crossing defects were observed. The number of neurons,
NSCs or glial cells, was, however, unaffected (Figures S3B and
S3C). Both alleles and transheterozygous combinations gave
indistinguishable phenotypes (Figure 2D; data not shown), and
expression of a lola-BAC was sufficient to rescue the axonal
guidance defects (data not shown), confirming the specific role
of this isoform in this process. We further generated a transgenic
line expressing Lola-F under the control of UAS promoter. Strik-
ingly, neuronal Lola-F expression inwild-type embryos disrupted
the VNC, mimicking the lola-F mutant phenotype (Figure 2D).
However, neuronal Lola-F cDNA expression in lola-F KO
embryos completely restored the axonal guidance defects,
which was not the case upon neuronal expression of Lola-H
or Lola-O cDNA (Figure 2D; data not shown). Altogether, these
data indicate that Lola-F plays amajor role in establishing axonal
guidance at the ventral midline, and they suggest that its physi-
ological levels must be tightly controlled to ensure its correct
function.
We next wondered whether other isoforms that are essential
during embryonic development were also involved in controlling
axonal pathfinding. As previously shown by in situ hybridization
(Goeke et al., 2003), we confirmed by RNA sequencing
(RNA-seq) of neuronal sorted cells from stage 15/16 embryos
that most isoforms were expressed in neurons. Lola-A, -F, -H,
-K, and -N were most strongly expressed, while Lola-J, -M, -O,
and -B were barely detectable (Figure S4A). Lola-K and -L
were already shown to control muscle innervation by ISNbmoto-
neurons, a phenotype we could recapitulate; we also could
demonstrate that Lola-F plays a similar function (Figure S2C).
However, neither the depletion of Lola-K and -L nor the absence
of Lola-N and -T altered axon guidance at the ventral midline
(Figure S2F). Only lola-K mutants occasionally displayed
crossing defects between the A5 and A6 hemisegments. Hence,(F) (Top) Immunostaining of VNC using anti-Fasciclin II antibody (green) to analyze
axonal midline crossing of lola-Fstop, lola-FZNF, and lolaE76 embryos. Arrowhead
events is shown (n = 9 for lola-Fstopand lolaE76; n = 8 for lola-FZNF). Significance w
represented as average ± SEM.
See also Figure S5.our data indicate that Lola-F is the major isoform required in
axonal pathfinding at the ventral midline for which lola is named.
Lola-F Activates Expression of Several Genes Involved
in Axon Guidance
Previous studies reported the involvement of Lola in axon guid-
ance, in part by upregulating the levels of the repulsive ligand
Slit and its receptor Robo at the ventral midline (Crowner et al.,
2002), while its effect on axon growth could partly be explained
by downregulation of the actin nucleation factor Spire (Gates
et al., 2011). To get further insights into the mechanisms by
which Lola controls axon growth and guidance, we took advan-
tage of our specific lola-Fstop allele to perform transcriptome
analysis at stage 15, when the majority of axon guidance events
are taking place. We also included samples from lolaE76-null
mutant embryos to compare the affected genes with the
absence of lola-F. We found that 465 and 586 genes were signif-
icantly upregulated and downregulated in lola-F KO embryos,
respectively (adjusted p value < 0.01). Intriguingly, gene ontology
(GO) term analysis revealed enrichment for genes involved in cell
adhesion and axon extension specifically for downregulated
genes, underlining the role of Lola-F in regulating axonogenesis
(Figures 3A and S5A). 217 (37%) downregulated genes were
mutually found in the lola-null mutant, including the previously
described targets slit and robo1 (Figures 3A, 3B, S5B, and
S5C). However, in contrast to the null allele, lola-F mutants
showed no significant change in spire expression (Figures 3B
and S5D), indicating that other isoforms must control its level.
The absence of spire regulation by Lola-F might account for
the milder effect observed on axon growth compared to the
complete loss of lola (Figure 2D). Furthermore, potential antago-
nistic isoform-specific Lola functions might nullify each other’s
effect, thus explaining that a subset of genes affected in the
lola-F mutant is not present in the null allele.
Among the top 15 downregulated genes in both lolaE76 and
lola-FStop mutants is futsch, a well-characterized and conserved
axon guidance gene (Figure 3A). The axonal defects observed
for lola-F KO embryos mimicked the previously characterized
futschK68 mutant phenotype, as embryos showed disrupted
VNC motoraxons and stalling of the peripheral ISNb motornerve
(Hummel et al., 2000; Figure S2C). The reduction in futsch levels
was confirmed by qRT-PCR and in situ hybridization (Figures
3B–3D). Immunostaining using a Futsch-specific antibody on
lola-FStop embryos showed an overall reduced fluorescent inten-
sity, indicating that the protein level was also decreased (Fig-
ure 3E). To examine whether the effect on futsch expression in
the absence of Lola-F activity contributes to the observed phe-
notypes, we wondered whether restoring its levels could rescue
some of the lola defects. To this purpose, an EP element inser-
tion line containing UAS-regulatory elements located in the pro-
moter region of futsch was crossed with the neuronal elav-GAL4midline-crossing events. Ectopic neuronal Futsch expression partially rescues
s indicate axon guidance defects. (Bottom) Quantification of midline-crossing
as tested using ANOVA one-way t test (***p < 0.001 and **p < 0.01). Data are
Cell Reports 21, 2911–2925, December 5, 2017 2915
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Figure 4. lola-O KO Flies Display a Severe Neuronal Degeneration Phenotype
(A) Scheme of the lola-O genomic region and expected deletion.
(B) lola-O KO adult flies display melanotic masses (arrows), eventually leading to the loss of affected limbs (arrowhead).
(C) Phenotypic penetrance of melanotic masses is reduced to control levels by recombination with a lola genomic construct. 10 flies were examined in four
replicates at 11 days of age. ANOVA one-way t test was performed (***p < 0.001). Data are represented as average ± SEM.
(D–F) Survival curves of adult Drosophila. The average of three biological replicates is shown, and lola-O mutants recombined with the driver line serve as a
control. (D) Ubiquitous ectopic expression (Tub-GAL4) of lola-O cDNA elongates the lifespan of lola-O mutants by 2-fold. (E) Neuronal lola-O expression (elav-
(legend continued on next page)
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driver line. We found that embryonic progeny derived from this
cross displayed ectopic Futsch levels, yet axonal guidance
was normal (Figures S5E and S5G). Similar elevated Futsch
levels were observed in embryos deficient for Lola-F. Remark-
ably, this ectopic Futsch expression was sufficient to partially
restore both VNC and ISNb axonal defects for both lola-F alleles
and the lola-null mutant (Figures 3F and S5F). It is noteworthy
that neuronal overexpression of lola-F did not result in elevated
futsch levels, indicating that ectopic lola-F expression alone
was not sufficient to transcriptionally activate futsch (Figures
S5H and S5I). Furthermore, previous findings have shown that
Futsch expression is negatively regulated by a splice variant of
Tramtrack (Ttk) (Giesen et al., 1997). To analyze whether the
observed axon guidance phenotype in lola-Fmutants was medi-
ated by a change in Ttk levels, we analyzed ttk expression in
lola-FStop embryos (Figure S5J). We found that both ttk isoforms
displayed a slight downregulation upon Lola-F depletion, indi-
cating that the observed axon guidance phenotype was not a
consequence of increased Ttk levels. Collectively, our findings
demonstrate that Lola-F regulates axonal pathfinding by acti-
vating numerous axon guidance genes, including the microtu-
bule-associated encoded gene futsch.
lola-O Mutant Flies Display a Severe Degeneration
Phenotype
We next investigated the function of Lola-O in vivo. We gener-
ated one mutant allele that was expected to disrupt the entire
zinc-finger domain (Figure 4A). The lack of mRNA expression
was confirmed by qRT-PCR and RNA-seq using RNA extracts
from control and mutant strains (Figures S6A and S6B). Deple-
tion of lola-O results in homozygous viable animals, yet adult flies
displayed several abnormalities, including reduced lifespan and
severe locomotion defects (Figures S6C and S6D). In addition,
females exhibited cuticle malformation and suffered from partial
sterility (Figures S6E and S6F). Both males and females also
frequently formed melanotic masses (also called pseudotu-
mors), which occurred predominantly on abdomen and limbs
(Figures 4B and 4C). Melanotic masses were also occasionally
observed in third instar larvae (Figure S6G). Importantly, all these
phenotypes could be rescued by a genomic construct restoring
lola-O, ruling out off-target effects. Likewise, ubiquitous or
ectopic neuronal lola-O expression was sufficient to restore
the lifespan and reduce phenotypic penetrance of lola-O KO flies
(Figures 4D, 4E, 4G, and S6H). In contrast, glial expression had
no effect (Figure 4F). Taken together, these findings indicate
a neuronal role for Lola-O in regulating multiple physiological
functions.
lola-O Is Specifically Expressed in OA Neurons
To obtain insights into Lola-O function, we sought to address
its localization in vivo. For this purpose, we took advantage of
a fly line carrying a lola-BAC encoding a Lola-O-GFP fusionGAL4) restores longevity of lola-O mutant flies to wild-type levels. (F) Glial cell-sp
lola-O KO flies.
(G) Half-life quantification. Half-life is defined as the day with 50% survival. Four
See also Figure S6.protein (Spokony and White, 2012). We found that Lola-O
was generally expressed at a very low level in the larval brain,
just at the limit of its detection. However, the low Lola-O-GFP
expression was refined to only a subset of cells, which included
the midline and lateral midline of the ventral ganglion and a few
groups of cells in the central brain (Figure 5A). To reveal the
identity of these cells, we crossed flies carrying a UAS-GFP
transgene reporter with flies expressing GAL4 under the control
of various neuronal promoters, and the resulting GFP expres-
sion was subsequently compared to the expression pattern
of Lola-O. Interestingly, GFP expression driven by the Tdc2-
GAL4 driver was reminiscent of the expression of Lola-O-GFP
(Figure 5B).
Tdc2 stands for Tyrosine-decarboxylase and encodes for an
enzyme required for the synthesis of OA (Figure 6A). OA acts
as a neurotransmitter, neuromodulator, and neurohormone in
insects, and it is involved in diverse physiological functions.
Notably, perturbation of its level results in phenotypes reminis-
cent of the loss of Lola-O, including locomotion defects, cuticle
deformity, the appearance of pseudotumors, female sterility,
and the shortening of lifespan (Figure 6B; Monastirioti et al.,
1996; Stathakis et al., 1999; Saraswati et al., 2004; Li et al.,
2016). Its synthesis requires the amino acid tyrosine, which is
modified to tyramine by the Tyrosine-decarboxylase 2 (Tdc2).
Subsequently, Tyramine b-hydroxylase (TBH) hydrolyzes tyra-
mine to produce OA (Figure 6A; Barron et al., 2010; Li et al.,
2016).
To confirm the expression of Lola-O in OA neurons, larval
brains were stained for both Lola-O-GFP and an antibody that
recognizes TBH, which was shown to be a faithful marker of
OA cells (Selcho et al., 2012). We found that TBH and Lola-O-
GFP co-localized in a cluster of dorsomedial cells in the larval
brain and along the midline of the VNC. Single cells lateral of
themidline were only positive for Lola-O-GFP (Figure 5C). There-
fore, our data suggest that Lola-O function may be linked to the
OA pathway. We also performed transcriptome analysis on
OA cells sorted via fluorescence-activated cell sorting (FACS)
of stage 17 embryos. We found that lola-A, lola-K, and lola-L
were strongly expressed, while the read coverage was not
sufficient to detect lola-O mRNA, confirming that this isoform is
expressed at low levels in OA cells (Figure S4B).
Expression of lola-O cDNA in OA Neurons Is Sufficient to
Rescue Most lola-O Mutant Defects
To address a potential role of Lola-O in the OA pathway, we per-
formed a drug-feeding assay in which lola-O KO flies were sup-
plied with OA-enriched food. Interestingly, ectopic feeding of OA
to lola-Omutants was sufficient to elongate the half-life by 2-fold
(12 days ± 2.6 versus 21 days ± 3.6, p value < 0.05), while feeding
the same flies with tyrosine had no effect (Figures 6C and
6D). We verified that feeding TbhnM18 mutant flies with OA res-
cues the half-life to a similar extent (Figure 6B). Furthermore,ecific (repo-GAL4) lola-O expression is unable to rescue premature lethality of
biological replicates were analyzed. Data are represented as average ± SEM.
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Figure 5. Lola-O Co-localizes with OA Neurons in the Larval Brain
(A) Immunostaining of Lola-O-GFP using an anti-GFP antibody (green; DAPI, cyan).
(B) Tdc2-GAL4 expression pattern in the larval brain revealed with an anti-GFP antibody (green). OA cells are present in the VNC along the midline and in a subset
of cells in the central brain (arrowheads), similar to the Lola-O-GFP expression.
(C) Lola-O (anti-GFP, green) and TBH (magenta) co-localize in the larval central brain and in cells along the VNC (arrowheads). Individual Lola-O-positive cells at
the lateral midline show no TBH immunoreactivity (arrows).
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Figure 6. lola-O KO Flies Can Be Rescued by Feeding OA
(A) Scheme of the OA pathway.
(B) Longevity is drastically reduced in TbhnM18 flies. FeedingOA extends the lifespan bymore than 2-fold, while supplementing tyrosine has no effect. The average
of two biological replicates is shown.
(C) Rearing lola-O KO flies on OA-enriched food elongates longevity by 2-fold, while tyrosine feeding has no effect on survival. The average of three biological
replicates is shown.
(D) Quantification of the half-life deduced from (C). Feeding OA to lola-O mutants increases the half-life from 10.6 to 21.8 days. ANOVA t test was applied
(**p < 0.001). Data are represented as the average of three biological replicates ± SD.
(E) Feeding OA to lola-O mutants enhances climbing efficiency. Three-day-old male flies were used for locomotion quantification in three biological replicates.
ANOVA one-way t test was performed to test statistical significance (*p < 0.05). Data are represented as average ± SD.
(F) 10 freshly hatchedmales and females were analyzed formelanoticmasses at 11 days. ANOVA one-way t test was applied (***p < 0.0001). Data are represented
as the average of four biological replicates ± SEM.
See also Figure S6.OA-enriched food improved locomotion of lola-Omutants, and it
reduced the occurrence of pseudotumors close to wild-type
levels (9.86% on OA-enriched food compared to 35.71% on
control food) (Figures 6E and 6F). Thus, these results strongly
suggest that the defects observed in lola-O KO flies result from
reduced levels of OA.
We reasoned that if Lola-O function was solely required in OA
cells, expressing Lola-O specifically in these cells should be
sufficient to rescue all defects associated with its loss. To test
this hypothesis, UAS-Lola-O flies were crossed with the Tdc2-
GAL4 driver, which completely restored survival of lola-O mu-
tants aswell as their climbing ability and the appearance of pseu-
dotumors (Figures 7A, S7A, and S7B). Furthermore, the fertility of
mutant flies was also partially rescued, demonstrated by the
improved egg-laying rate (Figure S7C). In contrast, expression
of either UAS-Lola-F or UAS-Lola-H in OA cells was unable to
restore the survival of lola-O KO flies (Figure S7D). Altogether,
these experiments demonstrate that the primary activity of
Lola-O is restricted to OA neurons.Lola-O Regulates the OA Pathway via the Control of Tbh
Expression
OA is synthetized via the activity of two enzymes, Tdc2 and TBH.
To test whether Lola-O controls their expression in vivo, we
analyzed transcript levels from RNA isolated from adult heads
of control and lola-O KO flies by qRT-PCR. Intriguingly, while
Tdc2 expression was unaffected in lola-O mutants, the level of
TbhmRNA was significantly reduced (Figure 7B). A similar result
was observed in a transheterozygous combination in which lola-
O mutants were crossed with a lola deficiency line (data not
shown). We also found that TBH protein levels were decreased,
as shown by reduced TBH immunoreactivity in brains of lola-O
KO larvae (Figure S7E). The specificity of the TBH staining was
confirmed, as the signal was essentially absent in the brains of
TbhnM18 mutant larvae (Figure S7F). Collectively, these results
indicate that Lola-O is required to maintain proper Tbh levels.
Given the reduced abundance of Tbh in lola-O mutants, we
wondered whether ectopic expression of Tbh cDNA would
restore longevity and phenotypic penetrance of these flies. WeCell Reports 21, 2911–2925, December 5, 2017 2919
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Figure 7. Lola-O Regulates the OA Pathway via the Activation of Tbh Expression
(A) Expression of lola-O in OA neurons restores wild-type longevity. The average of three biological replicates is shown.
(B) qRT-PCR using mutant RNA extract isolated from freshly eclosed adult male heads. ANOVA one-way t test was performed (***p < 0.001 and *p < 0.05). Data
are represented as the median of three technical replicates ± SD.
(legend continued on next page)
2920 Cell Reports 21, 2911–2925, December 5, 2017
generated flies with integrated Tbh under the control of a UAS-
promoter, andwe induced expression using different GAL4 lines.
Strikingly, expression of Tbh using a neuronal driver line rescued
fly survival and significantly decreased the occurrence of pseu-
dotumors (Figures 7C and 7D). These findings therefore demon-
strate that Lola-O regulates the OA pathway via the control of
Tbh expression.
To uncover the transcriptional network regulated by Lola-O,
we aimed to identify the Lola-O genome-wide binding sites,
and we compared our findings with genes differentially ex-
pressed upon Lola-O depletion. For this purpose, we took
advantage of the Targeted DamID (TaDa) approach to identify
direct target genes in OA neurons (Southall et al., 2013). Expres-
sion of N-terminally tagged Dam-Lola-O was induced by the
driver line Tdc2-GAL4, and embryoswere processed at stage 17.
The same experiment was repeated with Dam-RNA polymerase
II (Pol II) to identify transcriptionally active genes in OA neurons.
We found 1,449 genes bound by Pol II and 7,327 by Lola-O, while
905 were shared by Lola-O and Pol II (with a false discovery rate
[FDR] of < 0.01). Furthermore, we found an overlap of 32.7%with
differentially expressed genes (296) in lola-O mutants of the
same developmental stage (Figure S7G). While Tbh was not
among the Lola-O targets (Figure S7H), we identified the gene
Bacc, which encodes a repressor of Tbh (Chen et al., 2013), as
directly bound and repressed by Lola-O (Figures 7E–7G). There-
fore, our results suggest a model whereby Lola-O regulates TBH
levels indirectly, possibly via the repression of Bacc expression.
DISCUSSION
Here we describe a comprehensive functional characterization
of the different Lola isoforms in vivo. Using the CRISPR/Cas9
approach, we generated mutants for every lola isoform, and
we demonstrated that lola-F mutants mimic the characteristic
lola-null mutant phenotype observed during embryogenesis.
We further uncovered a function for Lola in the OA pathway
mediated by Lola-O activity via the regulation of Tbh. In addition
to revealing novel Lola functions, this study demonstrates that
the recently developed CRISPR/Cas9 system can be used to
systematically address isoform-specific functions in vivo.
Assigning Lola Function to Specific Isoforms
Lola is among the most complex loci in Drosophila, encoding for
20 different protein isoforms via the usage of 30 alternative exons.
Its complete loss of function gives rise to pleiotropic defects
in vivo, which have been difficult to analyze at the molecular level
due to the paucity of specific mutant isoforms. First described in
1993 by Giniger and colleagues, Lola was shown to control axon
growth and guidance in both the CNS and peripheral nervous
system (PNS) of the Drosophila embryo (Giniger et al., 1993).
However, it remained unclear how it exerts these functions and(C and D) Neuronal Tbh expression (elav-GAL4) restores longevity (C) and the occu
replicates is shown in (C).
(E and F) Track example of poly-A-selected RNA-seq at theBacc locus. (E) lola-O K
in (F). RNA was isolated from stage 17 embryos (20–22 hr AEL). ANOVA one-wa
(G) Lola-O and Pol II binding to the Bacc locus in OA cells. Vertical bars show lo
See also Figure S7.whether these effects depend on a specific Lola isoform or
on the activities of multiple ones. Our results clearly establish
Lola-F as being themain isoform required in these early develop-
mental processes.
A previous transcriptomic analysis from lola-null mutant ex-
tracts suggested that Lola controls axonal guidance by fine-tun-
ing the expression of many genes involved in this process, and it
is the sum of small changes on many genes that give rise to the
severe lola-null mutant phenotype (Gates et al., 2011). Neverthe-
less, several key targets could be identified. For instance, in the
CNS, Lola was suggested to repel longitudinal axons away from
the midline by increasing the expression of the midline repellant
Slit and its axonal receptor Robo (Crowner et al., 2002). In the
PNS, Lola controls ISNb axonal growth partially via reducing
the expression of the actin nucleation factor Spire (Gates et al.,
2011). In spite of Lola-F being involved in both processes, we
found that only slit and robo expression was altered, while spire
was unchanged. Furthermore, our study revealed futsch as be-
ing a key target of Lola-F in axon growth. Futsch is a microtu-
bule-associated protein whose expression levels need to be
tightly controlled. For instance, heterozygous animals display
mutant phenotypes, including slower growth rates and motor
system abnormalities, indicating that its dosage is critical for
its function (Edelmann et al., 1996). Moreover, its expression in
the somatic and visceral musculature is repressed by Tramtrack
(Giesen et al., 1997). It is interesting to note that Tramtrack, like
Lola, encodes for a zinc-finger and BTB domain-containing pro-
tein, suggesting that this class of proteins plays a prominent role
in either repressing or activating Futsch expression. Previous
studies on several BTB-containing proteins demonstrated that
the BTB domain mediates homomeric and heteromeric dimer-
ization and transcriptional repression through the recruitment
of diverse co-repressor proteins (Bardwell and Treisman, 1994;
Dhordain et al., 1997). Our data, however, indicate that Lola-F
is a general activator of neuronal genes. Further interactome
studies will, therefore, be necessary to understand how different
BTB proteins exert antagonistic molecular functions on gene
expression.
The expression of Lola-F drops as Drosophila development
progresses and becomes primarily restricted to NSCs. This
finding suggests that neuronal gene expression outside the
NSCsmust bemaintained by different means, such as via the ac-
tivity of other transcription factors or via an epigenetic mecha-
nism. Intriguingly, Lola-F was shown to interact early in develop-
ment with the histone H3S10 kinase JIl-1 (Zhang et al., 2003). Via
this molecular activity, JIL-1 maintains euchromatic regions by
antagonizing Su(var)3-9-mediated heterochromatin formation.
Therefore, it is possible that, during early development, Lola-F
establishes an active epigenetic state via its association
with JIL-1, and, once established, its function may become
dispensable. The remaining Lola-F expression in NSCs appearsrrence of melanoticmasses (D) of lola-OKO flies. The average of two biological
O embryos show upregulatedBacc levels, which were quantified by qRT-PCR
y t test was performed and data are represented as average ± SD (*p < 0.05).
g2 ratio between the Dam-only and Dam-fusion signal.
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important to maintain their differentiation capacity, as the double
knockdown (KD) of Lola-F and Lola-L leads to dramatic overpro-
fileration of NSCs in the central brain (Wissel et al., 2016). It will
be important to further identify the direct targets of Lola-F and
Lola-L in this process to understand how these two isoforms
cooperate to allow NSC differentiation.
Connection between Lola and the OA Pathway
Our findings demonstrate a regulatory role for Lola-O in the
OA pathway by regulating Tbh expression, which encodes an
enzyme required for the synthesis of OA, a monoamine that
acts as a neurohormone, neuromodulator, and neurotransmitter
(Nathanson, 1979). Monoamine neurotransmitter levels are usu-
ally tightly regulated, as their misregulation can lead to a wide
range of disorders in humans (Ng et al., 2015). Accordingly,
several lines of evidence indicate that the absolute levels of OA
must also be tightly controlled. For instance, reducing its
levels leads to diverse defects, including female sterility, loco-
motion, aggressiveness, and pseudotumor formation (Monastir-
ioti et al., 1996; Saraswati et al., 2004; Zhou et al., 2008), while
increasing its level also leads to similar abnormalities (Stathakis
et al., 1999). Despite this dosage-function dependency, very little
is known about the mechanisms controlling OA synthesis
throughout the Drosophila life cycle. Studies on honeybees
have shown that OA synthesis increases with age (Harris and
Woodring, 1992), which might be also the case in Drosophila.
Additionally, it has been shown that stress can induce OA syn-
thesis in the hemolymph of both locusts and cockroaches
(Davenport and Evans, 1984), implying that differential concen-
trations of OA are required in response to altered environmental
circumstances. Recent reports demonstrated a FOXO-mediated
increase in OA metabolism upon elevated temperatures in
Drosophila (Gruntenko et al., 2016). It would, therefore, be inter-
esting to test whether TBH expression is also stress induced and
whether Lola-O contributes to this effect.
We show that Lola-O binds and negatively regulates Bacc, a
previously characterized repressor of Tbh. Heterozygous Bacc
mutants display only mild upregulation of Tbh levels, which is,
however, sufficient to induce elevated OA synthesis, leading
to acute ethanol sensitivity (Chen et al., 2013). These findings
suggest that Bacc expression requires a precise regulation to
control OA synthesis.
Future Directions
Our study illuminates a novel role for Lola in controlling neuro-
transmitter signaling. Interestingly, Lola-O expression appears
to be completely restricted to TBH-positive cells in the larval
CNS, albeit at very low levels. The mechanisms that restrict
Lola-O expression to this subset of cells are currently unknown.
It is widely known that promoter activity can influence and
determine tissue-dependent gene expression, suggesting that
expression of Lola-O in OA neurons might be a consequence
of alternative promoter activity. lola is encoded by four pro-
moters, with expression of all isoforms from all four promoters
(Ohsako et al., 2003); yet, cell-type-specific promoter activity
has not been addressed. Alternatively, a splicing regulator might
be specifically expressed in OA-responsive cells, promoting the
expression of Lola-O exclusively in these cells. Additional exper-2922 Cell Reports 21, 2911–2925, December 5, 2017iments are needed to further reveal the mechanism of the
restricted expression of Lola-O in the brain and to address
whether analogous mechanisms apply in vertebrates to control
the level of norepinephrine upon normal and disease conditions.
EXPERIMENTAL PROCEDURES
Fly Stocks
Drosophila melanogaster w1118 was used as the wild-type control. For rescue
experiments, the following driver lines were used: Tdc2-GAL4, Tub-GAL4, and
elavC155-GAL4.Df(2R)ED2076 served for the generation of trans-heterozygous
lola mutants. PBac(lola.J-GFP.FLAG)VK00033 and PBac(lola.GR-GFP.FLAG)
were used for rescue experiments (Spokony and White, 2012). For
transcriptome analysis, lolaE76 and lola-FStop flies were balanced with w*;
P{sqh-mCherry.M} to enable selection of homozygous embryos based on fluo-
rescence (Martin et al., 2009). P{w[+mC] = EP}futsch[EP1419] served for the
rescue experiment of lola-FStop embryos. MARCM clones were generated us-
ing the following lines: lola-N, FRT42D/CyO, FRT42D/CyO and elav-GAL4,
UAS-mCD8-GFP, hsFLP; FRT42D, tub-Gal80 (kind gift from C. Berger). Flies
were obtained at the Bloomington Drosophila Stock Center. Tbhnm18 mutant
flies were a kind gift from M. Monastirioti and UAS-LT3-Dam-Pol II and
UAS-LT3-Dam flies were a kind gift from A. Brand.
CRISPR/Cas9 Mutant Flies
gRNA sequences were cloned into pBFv-U6.2B (Kondo and Ueda, 2013),
sequenced, and injected in our lab into y1 v1 P(nos-phiC31yint.NLS)X;
attP40. Transgenic flies were further crossed with y2 cho2 v1; attP40(nos-
Cas9)/CyO, and flies from the F1 generation were PCR-screened for the
expected mutation using primer sequences flanking the gRNA sequences
(Table S2). Obtained PCR amplicons were sequenced at GATC Biotech.
UAS Constructs
Coding sequences of lola-A, -O, -F, and -H and Tbhwere amplified from cDNA
and inserted into Gateway plasmids with N-terminal FLAG-Myc or FLAG-HA
tag (pPFMW or pPFHW, respectively; obtained from Drosophila Genomics
Resource Center at Indiana University). All constructs were sequenced prior
to injection into w1118. Drosophila germline injection for lola-A and -F and
Tbh was performed in house. The construct for UAS-Lola-O and UAS-Lola-H
was injected at BestGene.
Drug-Feeding Assay
Flies were collected within 10 hr of eclosion, gender-separated, and placed on
medium containing 5 or 7.5 mg/mL OA or tyrosine for males and females,
respectively. Flies were examined daily for survival rate and phenotypic pene-
trance. 20 flies were used for each condition.
Locomotion Assay
20 freshly hatched male and female flies were separated and staged until
desired age. The locomotion was assessed using the climbing assay
described previously (Bahadorani and Hilliker, 2008). Flies were taped to the
bottom, and flies passing 8 cm in 10 or 5 s, respectively, were counted. Mea-
surements were repeated five times in three biological replicates.
Lifespan Assay
20 control or experimental flies were gender-separated within 10 hr of eclosion
and maintained at 25C. Survival was analyzed every 2 days and flies were
transferred to new vials twice a week.
Fertility Assay
10 female virgin flies were mated with 5 males for 3 days. Upon fertilization,
females were transferred onto fresh agar plates every 12 hr, and the number
of eggs laid was counted for 5 days.
Cell-Type-Specific Transcriptome Analysis
UAS-mCherry expression was induced in neurons by elav-GAL4 and in OA
cells by Tdc2-GAL4. Eggs were collected for 3 hr and aged for 13 or 20 hr,
respectively. Cell isolation was performed as described previously (Salmand
et al., 2011), and cells were sorted using the Becton Dickinson Aria III SORP
flow cytometer. For RNA preparation, 10 cells per replicate were collected in
lysis buffer and subjected to library preparation using the Smart-Seq2 Kit for
Illumina.
Transcriptome Analysis
lola-FStop and lolaE76embryoswere collected at 25C for 2hr and aged for 13hr.
Embryos were hand-sorted based onmCherry expression. lola-OKO embryos
were collected at 25C for 2 hr and developed for 20 hr. Mutant and control
embryos were transferred into TRIzol reagent (Thermo Fisher Scientific), and
they were subjected to RNA isolation using the manufacturer’s protocol.
cDNA Library Preparation
RNA was isolated, DNase I- (New England Biolabs) treated, and subjected to
library preparation using the NEBNext Ultra Directional RNA Library Prep Kit
for Illumina. 1 mg total RNA was used as starting material for cDNA library
preparation.
Computational Analysis
Libraries for transcriptome analyses were sequenced on the NextSeq500.
Cells sorted via FACS were sequenced as single-read 76 bp; the other sam-
ples were sequenced as 42-bp paired end. Demultiplexing and fastq conver-
sion were done with bcl2fastq (version [v.]2.19). Reads were mapped using
STAR (v.2.5.2b) against ensembl release 87 (BDGP6). For the cells sorted
via FACS, the reads were filtered for rRNA reads before mapping. Counts
per gene were calculated using featureCounts (v.1.5.1) with ensembl release
87 as a reference. Differential expression analysis was done using DESeq2
(v.1.16.1) with an FDR filter of 1%. Transcript quantification for the cells sorted
via FACS was performed using stringtie (v.1.3.3b) and visualized using ball-
gown (v.2.8.4). Splice junction quantification and visualization was done using
SGSeq (v.1.10).
GO Term Method and Plot Outline
GO terms overrepresentation was calculated using GOStats (v.2.38.1)
requiring a minimal amount of 5 genes per GO term and adjusted p value
smaller than 1%. Afterwards, terms were summarized using semantic similar-
ity (GOSemSim 1.30.3). Only GO terms with an odds ratio larger than 5 are
displayed.
Targeted DamID
UAS-Dam-lola-O flies were generated by amplifying and cloning the Lola-O
coding sequences into pUASTattB-LT3-NDam (kind gift from A. Brand).
UAS-LT3-Dam-lola-O and UAS-LT3-Dam-Pol II flies and UAS-LT3-Dam flies
(control) were crossed with Tdc2-GAL4 to induce octopaminergic expression
of the Dam fusion proteins. DNAwas isolated from embryos (20–22 hr after egg
laying [AEL]), and subsequent treatments were performed as described
(Marshall et al., 2016). Purified and processed genomic DNA of two biological
duplicates was subjected to library preparation using the NebNext DNA Ultra II
library kit (New England Biolabs) and sequenced on a NextSeq500. The first
read was mapped to Drosophila melanogaster genome (BDGP6) using bowtie
(v.2.2.9), binned to GATC fragments, and normalized against the Dam-only
control (Marshall and Brand, 2015). Peaks were called and mapped to genes
using a custom Perl program (available upon request).
qRT-PCR
Total RNA was transcribed into cDNA using MMLV reverse transcriptase
(Promega). qRT-PCR analysis was performed using a ViiA7 real-time PCR sys-
tem (Applied Biosystems). Measurements were done in triplicates. Relative
RNA levels were normalized to rpl15 levels. Primer sequences are listed in
Table S2.
In Situ Hybridization
In situ hybridization was performed as previously described (Lence et al.,
2016). For fluorescent in situ hybridization, anti-DIG-HRP (1:1,000, Roche)
was applied, and probes were visualized using the tyramide signal amplifica-
tion (Alexa Fluor 568, Thermo Fisher Scientific).Whole-Mount Embryo Immunostaining
Embryos were fixed and washed with PBS with 0.3% Triton X-100. Primary
antibodies used were the following: mouse anti-Fas II (1:20; 1D4, DSHB), rat
anti-Elav (1:100; 7E8A10, DSHB), mouse anti-Repo (1:100; 8D12, DSHB),
mouse anti-22C10 (1:50; DSHB), mouse anti-Lola zf5 (1:100; 1D5, DSHB),
guinea pig anti-Dpn (1:50, kind gift from C. Berger), rat anti-TBH (1:75,
kind gift from M. Monastirioti), and rabbit anti-GFP (1:500; TP401, Torrey
Pines Biolabs). Appropriate combinations of secondary antibodies (Jackson
ImmunoResearch Laboratories) were applied. Samples were analyzed with a
Leica SP5 confocal microscope.
Larval L3 Brain Immunostaining
Larval CNS was dissected in cold PBS, fixed for 20 min in 4% paraformalde-
hyde in PBS, and subsequently treated as embryonic samples. A confocal
stack was recorded using a Leica SP5 confocal microscope.
Western Blotting
Stagedembryoswere collectedandhomogenized in lysis buffer (140mMNaCl,
10mM Tris-HCl [pH 8], 1 mMEDTA [pH 8], and 0.5% Triton X-100). The protein
extract was separated on 8%SDS-PAGE gel followed bywestern blot analysis
with affinity-purified anti-Lola antibody (1:500, kindly provided by E. Giniger) or
Lola-Zf5 antibody (1:100; DSHB). For visualization, ultra-sensitive enhanced
chemiluminescent reagent (Thermo Fisher Scientific) was used.
Statistical Analysis
Statistical parameters and significance are reported in the figures and figure
legends. For comparisons of the means of two groups, Student’s t test was
used. For comparisons among more than two groups, the one-way ANOVA
was performed followed by multiple comparisons using t tests with Bonferroni
normalization of p values.
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